Shire to participate at two upcoming investor conferences
September 07, 2017 07:01 ET
|
Shire Pharmaceuticals Group
Shire to participate at two upcoming investor conferences Lexington, MA, USA - September 7, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Flemming Ornskov, MD, Chief Executive Officer,...
Shire plc : Total voting rights
September 01, 2017 06:31 ET
|
Shire Pharmaceuticals Group
Total Voting Rights September 1, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure...
Shire plc : Director/PDMR Shareholding
August 29, 2017 10:31 ET
|
Shire Pharmaceuticals Group
Director/PDMR Shareholding August 29, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transaction by person discharging managerial responsibilities 1. Details of the person discharging...
Shire plc : MYDAYIS(TM) (mixed salts of a single-entity amphetamine product), Shire's New Once-Daily ADHD Treatment, Now Available in the U.S.
August 28, 2017 07:00 ET
|
Shire Pharmaceuticals Group
For U.S. Audiences Only MYDAYIS(TM) (mixed salts of a single-entity amphetamine product), Shire's New Once-Daily ADHD Treatment, Now Available in the U.S. Mydayis, which is now...
Shire plc : Shire Announces Collaboration with MicroHealth to Address Unique Needs of Hemophilia A and B Patients with Inhibitors
August 25, 2017 07:00 ET
|
Shire Pharmaceuticals Group
Shire Announces Collaboration with MicroHealth to Address Unique Needs of Hemophilia A and B Patients with Inhibitors Collaboration leverages digital technology to provide free and secure care...
Shire plc : Director/PDMR Shareholding
August 23, 2017 07:01 ET
|
Shire Pharmaceuticals Group
Director/PDMR Shareholding August 23, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transaction by person discharging managerial responsibilities 1. Details of the person discharging...
Shire plc : Director/PDMR Shareholding
August 22, 2017 11:31 ET
|
Shire Pharmaceuticals Group
Director/PDMR Shareholding August 22, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transaction by person discharging managerial responsibilities 1. Details of the person discharging...
Shire plc : Director/PDMR Shareholding
August 22, 2017 08:01 ET
|
Shire Pharmaceuticals Group
Director/PDMR Shareholding August 22, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transaction by person discharging managerial responsibilities 1. Details of the person...
Shire plc Director and Senior Management Changes
August 21, 2017 09:00 ET
|
Shire Pharmaceuticals Group
Shire plc Director and Senior Management Changes August 21, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) ("Shire" or the "Company"), announces changes to its Executive Committee, as it progresses...
Shire announces submission of lifitegrast Marketing Authorization Application for treatment of dry eye disease in Europe
August 15, 2017 02:02 ET
|
Shire Pharmaceuticals Group
Shire announces submission of lifitegrast Marketing Authorization Application for treatment of dry eye disease in Europe Lifitegrast, if approved, would be the first and only new class...